Histosonics raises $102M for noninvasive treatment to destroy tumors

MedTech Dive August 19, 2024
Susan Kelly

Using sound waves to break down tumor tissue can offer patients with liver cancer an alternative to surgery, radiation and chemotherapy.

Dive Brief:

• Histosonics, whose technology targets liver tumors with ultrasound pulses delivered from outside the body, has raised $102 million in new funding to support further development and commercial growth of the platform.
• The company’s histotripsy system, which gained de novo authorization in October from the Food and Drug Administration, employs sound waves to break down and destroy tumor tissue, offering a noninvasive alternative to cancer treatments such as surgery, radiation and chemotherapy, which can have severe side effects.
• The Series D financing will be used to advance work on the Edison histotripsy platform and support commercial growth...

Today's Sponsors

Today's Sponsor